INTRODUCTION
The success of radiation therapy depends on greater radiation-induced killing of tumor cells than normal cells. Increasing the proportion of tumor cells killed and/or decreasing the toxicities to normal cells can improve the therapeutic index of cancer treatment. Tumors show wide variations in their response to ionizing radiation, which could be attributed to tumor heterogeneity, necrosis, lack of oxygen and the repair efficiency of tumor cells. [1] [2] [3] Various compounds are synthesized and tested to sensitize the tumor cells to radiation. [4] [5] [6] [7] [8] An ideal radiosensitizer for use as an adjuvant in radiotherapy should have such characterestics as low toxicity, high radiosensitizing efficiency for hypoxic cells, least effect on normal cells and minimum interference with other therapies; it should also be economically affordable. 4) Several nitro-imidazole compounds were found to significantly enhance the radiation induced killing of cells in vitro, and also in transplanted experimental tumors. 4, 5, 9, 10) Sanazole (AK-2123) (N-2′-methoxy ethyl)-2-(3″-nitro-1″-triazolyl) acetamide has a high radio-sensitizing efficiency on hypoxic cells, good solubility in water and comparatively low toxicity; it has also completed phase-lll clinical trials. 8, [11] [12] [13] Even though clinical studies of the 2-nitro imidazole sensitizers were undertaken at several places, the mechanism underlying their radio-sensitizing effect has not yet been well understood. Generally, radiosensitizers fix any radiation-induced DNA damage by reacting with macromolecular radicals and thereby inhibiting DNA repair. 10) Another hypoxic cell radiosensitizer, doranidazole has been shown to enhance the radiationinduced apoptosis of mouse lymphoma cell lines L5178Y, as reported earlier. 14, 15) The mechanism underlying radiosensitization by sanazole was investigated by pulse radiolysis and steady state gamma radiolysis studies. 16) Radiolytic studies on sanazole have revealed that it reacts with e aq -and OH radicals, yielding transients with λ-max as 295 nm and 290 nm with respective bimolecular rate constants of 3.6 × 10 10 dm 3 mol -1 S -1 .
17)
Depletion of intracellular non-protein thiols did not mitigate the radiosensitizing effect of sanazole in hypoxic cells. 17) By pulse radiolysis it was found that sanazole reacts with e aq -1 , CO 2-and 2-propanol radicals at almost diffusion-controlled rates, producing a nitro radical anion having an absorption maximum at 290 nm with in few microseconds. 17) It was reported that the decay kinetics of the radical anion was independent of the pH, and that the radical anion reacts with oxygen with a rate constant of 3.4 × 10 6 dm 3 ml -1 s -1 . 16, 17) An enhancement of radiation-induced DNA strand breaks by AK-2123 has been observed. Its effect on Saccharomyces cerevisiae has been demonstrated. 18) When sanazole was present during irradiation, it could specifically sensitize wildtype anaerobic Saccharomyces cerevisiae cells with a dosemodifying factor of 2.4. Studies on the wild-type and mutant rad 52 yeast cells exposed to radiation in presence of sanazole revealed that sensitization by sanazole is due to a preferential increase in the DNA damage, and not by impairing DNA repair.
18) Techntium-99m-cyclam AK-2123 has been synthesized, and upon the administration of tumor bearing animals this compound was found to have a tumor-to-tissue distribution ratio of 1:8. Hence it could be used for tumor imaging. 19) The present work concerns the mechanisms of radiosensitization by this drug with specific reference to the induction of apoptosis and alterations in the levels of the enzyme caspacse-3 involved in this process in murine fibrosarcoma. In vivo radiosensitization in murine fibrosarcoma has also been studied. The purpose of this study is to define the possible role of AK-2123 as the apoptotic inducer in tumour cells in vivo due to administration of the drug prior to irradiation. 
MATERIALS AND METHODS

Chemicals
Animals
Male Swiss mice, 8-10 weeks old, weighing 20-25 g, were selected from an inbred group in the animal house of this center maintained under standard conditions of temperature and humidity. Animals were provided food and water ad libitum. Usually, five animals were housed in each sterile polypropylene cage containing sterile paddy as bedding.
All of the animal experiments were conducted with strict adherence to the ethical guidelines laid down by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), constituted by the Animal Welfare Division of Government of India on the use of animals in scientific research.
Tumor transplantation
For studying radio-sensitization by AK-2123 on radiationinduced DNA strand breaks, a serially transplanted fibrosarcoma developed by subcutaneous injection of 6, 12-dimethylbenzo[1,2-b,5,4-b′]dithionaphthene was used as test system. 20) After fifteen-day old tumors were excised and minced, singlecell suspensions were prepared. A viable single-cell suspension of fibrosarcoma (10 6 cells in 0.2 ml saline) was transplanted by subcutaneous injection on the dorsal side of the hind limbs of the mice. When the tumor was grown to a diameter of 6-8 mm, the experiments were conducted.
Drug administration
Animals were administerd intraperitoneally with 40 mg/kg body weight of AK-2123 in saline at a concentration of 10 mg/ml. The animals received 4 µl of saline or AK-2123 in saline/g body weight.
Irradiation
Animals both injected intraperitoneally with saline or AK-2123 in saline 30 min before were immobilized and then whole-body exposed to 2 Gy, 5 Gy or 10 Gy of 60 Co γ-radiation in a specially designed well-ventilated acrylic box using a Theraton Teletherapy unit at a dose rate 0.50 Gy/min. For in vivo studies, local irradiation of the tumor was performed in a cage especially designed for local irradiation, and 5 animals were used in each group. The diameter of the spherical tumors was measured using Vernier calipers before and after irradiation and every alternate day in all of the control animals as well as the treated animals. The relative tumor diameter was calculated by dividing the diameter of the tumor measured on a particular day after the treatment by the diameter on the day of starting the treatment. Three sets of experiments were conducted.
Experimental protocol
The animals were divided into three groups as follows: 1, animals injected only with saline 1 h prior to irradiation; 2, animals injected with sanazole (AK-2123) in saline 1 h prior to irradiation; 3, animals injected with sanazole (AK-2123) in saline at the same time but not irradiated.
Animals were killed by cervical dislocation immediately or after 4 h or after 24 h, depending on the experiment performed. The tumor was dissected and preserved in phosphatebuffered saline.
Preparation of single cell suspension
A single-cell suspension of murine fibrosarcoma was prepared using a cell dissociation sieve tissue grinder kit from Sigma, Biochemicals & Reagents, USA, with a 50 mesh screen (cat log No. S-0895)
Microscopic analysis of apoptosis:
A thick suspension of cells was spread on slides and stained with Giemsa and May Grunwald according to a method of Chaubey et al. 21) The stained cells were visualized using bright field microscopy with Carl Zeiss Axioscope. Apoptotic cells were differentiated by condensed nuclei and fragmented nuclei. The number of apoptotic cells on each slide was counted in a total of 600 cells, starting from one side of the slide. The percentage of the apoptotic cells was then calcu-lated in each experimental group.
Assay of inter nucleosomal fragmentation
Apoptotic DNA was isolated using a kit obtained from Boehringer Mannheim (cat log No. 1 835 246) according to the manufacturer's protocol. After 1-2 µg of DNA was loaded on 1% agarose gel prepared in Tris-borate-EDTA buffer 22) electrophoresis was carried out at 70 V for 5-6 h. The resulting DNA was stained with ethidium bromide and photographed.
Caspase-3 assay
Caspase-3 in the cell free extract was assayed using a fluorimetric assay system from Promega (catlog No. G 3540) as per the manufacturer's protocol. The fluorogenic substrate for caspase-3 was Acetyl (Asp-Glu-Val-Asp)-AMC. The fluorochrome used for labeling the substrate was 7-amino-4-methyl coumarin (AMC), which is released from the substrate upon cleavage by caspase-3. A fluorescence spectrophotometer (Hitachi Model No. F-3010) monitored the fluorescence of free AMC at 460 nm using an excitation wavelength of 360 nm. The amount of yellow-green fluorescence produced upon cleavage was proportional to the caspase-3 activity present in the sample. The potent reversible aldehyde inhibitors of caspase-3 Ac-asp-Glu-Val-Asp-CHO were used to differentiate from the activities of other related proteinases. Figure 1 (A-D) shows microscopic photomicrographs of murine fibrosarcoma cells stained with Giemsa and MayGrunwald. In Fig. 1A it is observed that the majority of the cells are normal, and that there are some condensed nuclei which are undergoing apoptosis. In Fig. 1B the tumor-cell preparation from animals administered with 40 mg/kg body weight AK-2123 can be seen to have more condensed nuclei and fragmented nuclei. Figure 1C shows gamma radiationinduced apoptosis after exposure to a dose of 5 Gy. The difference in the number of apoptotic nuclei is evident from the photograph. Figure 1D shows the gamma radiation-induced apoptosis after the administration of 40 mg/kg body weight of AK-2123 prior to radiation exposure. In this photomicrograph majority of the cells are either condensed or fragmented. From Table 1 it is evident that upon exposure to a gammaradiation dose of 5 Gy, the apoptosis increased from 21% to 47%. Upon the administration of AK-2123, the increase in the number of apoptotic cells increased to 39%. On exposing the tumor after administering Ak-2123 to a dose of 5 Gy, the number of apoptotic cells was further enhanced to 57%. Figure 2 shows the formation of a DNA ladder in murine fibrosarcoma cells 24 h after following local irradiation to a dose of 2 Gy with or without the administration of AK-2123. From lane 1 it is evident that a considerable amount of apoptosis took place in murine fibrosarcoma cells. Lane 2 is the molecular weight marker 100 bp ladder and lane 3 shows apoptotic DNA isolated from the murine fibrosarcoma 24 h after exposure to a dose of 2 Gy. Lane 4 shows the DNA ladder isolated from murine fibrosarcoma cells of a mouse administered with AK-2123 and exposed to a dose of 2 Gy. Also, in lane 5 apoptotic DNA from animals administered with AK-2123 alone can be seen. Figure 3 shows the levels of caspase-3 enzyme in murine fibrosarcoma exposed to γ-rays to a dose of 2 Gy at a dose rate of (0.5 Gy/min) with or without the administration of AK-2123. It is evident that the level of the enzyme Caspase-3 was increased by radiation upon assaying for activity 4 h after radiation. The level of caspase-3 was found increased by AK-2123 administration. Upon exposure to radiation with a prior administration of AK-2123 the level of caspase-3 was further enhanced.
RESULTS
In Fig. 4 the relative tumour diameter is plotted against the days after irradiation. The growth curves of the control and those treated with AK-2123 alone, with radiation alone, AK-2123 and radiation are shown in Fig. 4 . AK-2123 alone at a dose of 40 mg kg -1 body weight did not influence the growth of the tumor. The growth curve of tumors treated with radiation alone and those treated with AK-2123 plus radiation showed a marginal difference in growth retardation. The difference in the growth retardation was significant initially on day 3. The difference was less on later days as the tumour started to grow, however. The results show a trend towards enhanced retardation of tumour growth during the period of the study.
The present study has shown that AK-2123 induces apoptosis in murine fibrosarcoma cells, as can be seen from the number of apoptotic cells. It also enhanced the level of caspase-3 enzyme and inter-nucleosomal fragmentation.
DISCUSSION
A number of studies on different mouse lymphoid and myeloid cell lines have shown evidence of apoptotic death followed by irradiation. 23, 24) The induction of apoptosis takes place in more slowly dying cell lines, in which cells appear to complete one or more mitoses before death. 23, 24) Radiation can induce apoptosis by several different pathways, including TP-53 mediated response to DNA damage and a pathway initiating at the cell membrane that generates the pro-apoptosis second-messenger ceramide. 25, 26) The role of hypoxia plays an important role in determining the radio-response of human tumors. 3, 27) It is known that the hypoxic component of a tumor increases with increasing tumor diameter. Clinically tumor hypoxia reduces the effectiveness of radiation therapy. Hypoxic cell radiosensitizers are useful in such situations. A recent study has shown that hypoxic short tissue sarcomas had a higher incidence of metastases compared to the well-oxygenated sarcomas. 4) Apoptosis is a cell autonomous death process that requires the active participation of endogenous cellular enzymes for the disassembly of the cells. 28, 29) A group of cell death enzymes, cysteine aspartases (caspases), that play an important role in apoptosis has been intensively studied. 29, 30) It plays an important role in embryonic development, metamorphosis, hormone dependent atrophy and tumor growth, as a physiological event regulating the cell number or eliminating damaged cells. Caspases may be divided into two classes based on the lengths of their N-terminal pro-domains. For example, caspases 1, 2, 4, 5, 8 and 10 have long prodomains. Caspases 3, 6, 7, 9 have short prodomains. The distribution of the prodomains may be of functional importance, the long prodomain appears to be involved in targeting and in regulating activation. 30) Caspase might be synthesized or activated in a tissue-specific manner. Caspase-3 is assumed by many to be the workhorse caspase of apoptosis, as studied by a knock out of the gene for this enzyme in mice. In the knock-out mice most apoptotic pathways were normal, with a selective defect in the cell death occurring in the central nervous system. 31) Caspases might be specialists in substrate destruction. Caspase-3 is an avid PARP protease and a poor lamin protease. 30) Caspase-3 activation is an early marker of apoptosis, whereas the inter-nucleosomal fragmentation of DNA is a late event of apoptosis.
30) The present studies reveal that the administration of sanazole prior to irradiation enhances both of these parameters in murine fibrosarcoma.
The nitroimidazole group of radiosensitizers are considered to sensitize hypoxic cells selectively by capturing macromolecular radicals, thereby acting to fix damage as well as to inhibit DNA repair. 4, 7, 10) It is known that DNA damage can enhance apoptosis, as demonstrated in studies with doranidazole. 14) It has been shown that 99m
Tc-cyclam AK-2123 complex accumulates specifically in hypoxic tumors. This complex could have a potential for detecting hypoxia and predicting radioresistance.
19) The mechanism of radio-sensitization by sanazole has been extensively studied. [32] [33] [34] The present study reveals its effect on apoptosis, an additional mechanism towards its radiosensitization property. The present observations indicate that it induces inter nucleosomal fragmentation and caspase-3 activity.
Classic hypoxic cell sensitizers, such as nitro-imidazoles, which act as oxygen substitutes to sensitize hypoxic cells to radiation damage, are highly neurotoxic. 10) Newer bio-reductive drugs, such as mitomycin C and Tirapazamine, which are selectively cytotoxic to hypoxic cells, are more successful, because they eliminate hypoxic cells and leave behind oxygenated cells that are more sensitive to radiation. 4, 35) Similarly, traditional chemotherapy can be used to kill welloxygenated cells, allowing the cells in the center of the tumor to become oxygenated, and thus more susceptible to radiation.
Radiation therapy activates the cells' sophisticated repair machinery, and if damage is quickly repaired the tumor continues to grow. To overcome the tumor cells' defense mechanisms, traditional radiosensitizers are often combined with radiation treatment to enhance the damage to tumor cells selectively by inducing more damage to DNA or inhibiting DNA repair. The radiosensitizer molecules damage tumours in a different way by inhibiting cell proliferation and enhancing apoptosis. When oxygen is absent, the radiation-induced molecular damages in cells are repaired immediately, but when oxygen is present, damage inflicted by radiationinduced free radicals in cellular macromolecules is fixed and becomes permanent. Hypoxic cells are about 2.5 to 3-times more radiation resistant. 1, 3) The traditional radiosensitizers can be used in treating solid tumors, whereas the new molecular agents can be used for all cancers, including leukemias and lymphomas. Some compounds are reported to be more effective as radiosensitizers in combination with hyperthermia, as in the case of bromodeoxyuridine and withaferin A. 36, 37) Wortmannin is shown to induce heat or X-ray induced cell death in cultured Chinese hamster V79 cells. 38) Sensitization to the hyperthermic treatment was considered to be mainly due to enhanced apoptotic cell death. 38) In the case of sanazole (AK-2123), the enhancement of apoptosis was also measured; tumor regression could be achieved by administrating of the compound, followed by fractionated radiotherapy, as in the case of withaferin A. 37) In the present study, considerable tumour regression could be seen on day 3 in tumour-bearing animals exposed to 5 Gy gamma-radiation following the administration of sanazole. The growth of the tumour, however, continued after day 3 at a rate slightly slower than the controls and those irradiated without administering sanazole. It may be possible to administer the drug and expose to another fraction of radiation on day 3 for a better and more effective control of tumour growth.
Our findings might have implications in the radiotherapy of cancer, because an enhancement of radiation-induced apoptosis in tumors could be a mechanism underlying radio-sensitization. Compounds capable of inducing this phenomenon could be useful as an adjuvant in the radiotherapy of cancer. Similar experiments on biopsy samples from human tumors collected before and after radiation therapy, with or without the administration of AK-2123, could throw more light on this. The results of in vivo studies in tumour-bearing swiss mice indicated a marginal enhancement of the retardation of tumour growth, upon the administration of AK-2123 prior to exposure to gamma-rays. This enhancement was significantly pronounced on the third day following the treatment. The present study also indicates that AK-2123 enhances gamma radiation-induced apoptosis. By the administration of AK-2123 prior to fractionated radiation exposure, it could be possible to achieve a more significant enhancement in retarding tumor growth.
